Ton Strategy Co

Aktienanalyse zu Ton Strategy Co (TONX)

$3.120

-0.257 (-8.24%)Zum Schluss

Loading chart…
High
3.400
Open
3.230
VWAP
3.20
Vol
1.91M
Mkt Cap
Low
3.090
Amount
6.11M
EV/EBITDA, TTM
159.60

Ton Strategy Company, formerly, Verb Technology Company, Inc. focuses on social commerce, social telehealth and social crowdfunding with MARKET.live, VANITYPrescribed, GoodGirlRx and the GO FUND YOURSELF TV Show. MARKET.live specializes in livestream and artificial intelligence (AI)-powered social commerce. MARKET.live platform is a multi-vendor, livestream social shopping destination at the forefront of the convergence of e-commerce and entertainment, where brands, retailers, creators, and influencers engage their customers, clients, fans, and followers across multiple social media channels simultaneously. GO FUND YOURSELF is an interactive social crowd funding platform and TV show for public and private companies seeking broad-based exposure across social media channels for their crowd-funded Regulation CF and Regulation A issuers; and a telehealth business unit that comprises two wellness-focused ecommerce sites, VanityPrescribed and GoodGirlRX.

AI analysis of Ton Strategy Co (TONX)

buy

Ton Strategy Co (TONX) is a good buy right now due to its current price of 3.25, which is significantly below its Fibonacci resistance levels, particularly the R1 at 3.425. The stock has shown a 5-day change of +6.21% and a year-to-date change of +34.85%, indicating positive momentum. Additionally, the company has initiated a buyback program under a $250 million authorization, which is expected to enhance shareholder value and reflects management's confidence in the stock's undervaluation. However, the main risk is the negative earnings trend, with a net income loss of -91,038,000 in Q1 2026, which investors should monitor closely.

Bewertungskennzahlen

The current forward P/E ratio for Ton Strategy Co (TONX) is 0.00, compared to its 5-year average forward P/E of -1.22.

Forward P/E

Overvalued
5Y Average P/E
-1.22
Current P/E
0.00
Überbewertet
-0.33
Unterbewertet
-2.10

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
-27.99
Current EV/EBITDA
159.60
Überbewertet
32.16
Unterbewertet
-88.14

Forward P/S

Fair
5Y Average P/S
33.52
Current P/S
22.37
Überbewertet
69.28
Unterbewertet
-2.25

Whales holding TONX

R

Ribbit Management Company, LLC

+ HoldingTONX

+19.94%

3M Return

A

Aristeia Capital, LLC

+ HoldingTONX

+4.07%

3M Return

V

Vy Capital

+ HoldingTONX

-9.57%

3M Return

Event-Zeitleiste

2026-07-16 (ET)

09:00:00

TON Strategy Expects $4M Financial Benefit in Q2 2026

2026-07-01 (ET)

08:30:00

TON Strategy Launches 2-Month Stock Repurchase Plan

2026-04-16 (ET)

16:10:00

TON Strategy Company Appoints Kevin Wilson as CEO

2026-03-31 (ET)

11:30:00

Bitfarms Achieves 72% Revenue Growth Ahead of Rebrand

2026-01-08 (ET)

09:00:00

TON Strategy Company Appoints Mary Marbach as General Counsel

News

TONX FAQ — answered by Alphio AI

Ton Strategy Company, formerly, Verb Technology Company, Inc. focuses on social commerce, social telehealth and social crowdfunding with MARKET.live, VANITYPrescribed, GoodGirlRx and the GO FUND YOURSELF TV Show. MARKET.live specializes in livestream and artificial intelligence (AI)-powered social commerce. MARKET.live platform is a multi-vendor, livestream social shopping destination at the forefront of the convergence of e-commerce and entertainment, where brands, retailers, creators, and influencers engage their customers, clients, fans, and followers across multiple social media channels simultaneously. GO FUND YOURSELF is an interactive social crowd funding platform and TV show for public and private companies seeking broad-based exposure across social media channels for their crowd-funded Regulation CF and Regulation A issuers; and a telehealth business unit that comprises two wellness-focused ecommerce sites, VanityPrescribed and GoodGirlRX. It operates in the Technology sector.

Ton Strategy Co (TONX) is a good buy right now due to its current price of 3.25, which is significantly below its Fibonacci resistance levels, particularly the R1 at 3.425. The stock has shown a 5-day change of +6.21% and a year-to-date change of +34.85%, indicating positive momentum. Additionally, the company has initiated a buyback program under a $250 million authorization, which is expected to enhance shareholder value and reflects management's confidence in the stock's undervaluation. However, the main risk is the negative earnings trend, with a net income loss of -91,038,000 in Q1 2026, which investors should monitor closely.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten